CareDx has developed innovative kit-based solutions for laboratories to enhance transplant monitoring. AlloSeq cfDNA (available outside the United States) and AlloSeq HCT incorporate significant advancements in cell-free DNA and chimerism testing, respectively, supporting early detection of relapse after transplant. We provide solutions that meet a wide range of needs, from initial matching to post-transplant monitoring and care.
TruSight HLA v2 Sequencing Panel provides clinical researchers with a broad-coverage, high–resolution human leukocyte antigen (HLA) typing solution for simple, rapid assessment of the HLA region in a single assay.
Assign software imports sequence data, performs base calling, enables sequence editing and compares a consensus sequence with a library of sequences of HLA alleles.